The CDC will review COVID-19 vaccine safety, as health experts criticize a potential lack of scientific basis for this move.

Those were in great demand at the beginning of the pandemic, and generated gobs of money for Pfizer. Demand has waned, though ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its senior management will present and meet with investors at upcoming investor conferences in the United ...

In October, the U.S. Centers for Disease Control and Prevention changed its guidance, recommending COVID vaccines only for adults 65 and older after consulting a doctor or pharmacist. Before that, the ...